Cerenome (CNSY) EBIT Growth (1y) (2012 - 2026)
Powered by 
Analysis
Cerenome (CNSY) EBIT Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 8.32% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 19.82% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 145.20% |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 10.14% |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 269.85% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 1,528.74% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -36.55% |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 99.51% |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | -488.88% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -488.88% |
| Mar 31, 2026 | -101.33% |
| Dec 31, 2025 | -47.23% |
| Sep 30, 2025 | -17.98% |
| Jun 30, 2025 | 58.40% |
| Mar 31, 2025 | -7.18% |
| Dec 31, 2024 | -1.09% |
| Sep 30, 2024 | -16.86% |
| Jun 30, 2024 | -148.12% |
| Mar 31, 2024 | 30.14% |
| Dec 31, 2023 | 30.76% |
| Sep 30, 2023 | 36.18% |
| Jun 30, 2023 | 70.90% |
| Mar 31, 2023 | -20.28% |
| Dec 31, 2022 | -41.46% |
| Sep 30, 2022 | -45.58% |
| Jun 30, 2022 | -98.83% |
| Mar 31, 2022 | -58.37% |
| Dec 31, 2021 | -16.02% |
| Sep 30, 2021 | -150.64% |